TURKISH JOURNAL OF MEDICAL SCIENCES, cilt.41, ss.719-724, 2011 (SCI İndekslerine Giren Dergi)
Aim: To investigate the in vitro activity of linezolid and ofloxacin in combination with first-line antituberculosis agents (isoniazid and rifampicin) against M. tuberculosis strains. The use of combinations that include fluoroquinolones and oxazolidinone is now being considered for the treatment of resistant Mycobacterium tuberculosis strains.